On August 1, 2008, the Senate approved H.R. 6432, the “Animal Drug User Fee Amendments of 2008,” which would to revise and extend the FDA’s animal drug user fee program, establish a program of fees relating to generic new animal drugs, and make certain technical corrections to the Food and Drug Administration Amendments Act of 2007. The House approved the measure on July 30, and it now awaits the President’s signature.